ERα is a well-established marker of breast cancer hormone sensitivity, and the quantification of estrogen receptors in breast tumors has been routinely performed in clinical laboratories to aid in the selection between hormonal and chemotherapy and also to predict prognosis. Because of ERα's critical role in cell biology, it is important to measure the total amounts of ERα contained in different cell types and tissues.

